Induction chemotherapy and post-remission imatinib therapy for de Novo BCR-ABL-positive AML

Research output: Contribution to journalArticle

Details

Authors
  • Vladimir Lazarevic
  • Irina Golovleva
  • Ida Nygren
  • Anders Wahlin
Organisations
External organisations
  • Norrland University Hospital
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Hematology
  • Pharmaceutical Sciences

Keywords

  • Aged, Antineoplastic Agents, Benzamides, Fusion Proteins, bcr-abl, Humans, Imatinib Mesylate, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Male, Piperazines, Pyrimidines, Remission Induction
Original languageEnglish
Pages (from-to)470-1
Number of pages2
JournalAmerican Journal of Hematology
Volume81
Issue number6
Publication statusPublished - 2006 Jun
Publication categoryResearch
Peer-reviewedYes